Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

COVID-19 Prevention: Vitamin D Is Still a Valid Remedy

Nicoll et al., Journal of Clinical Medicine, doi:10.3390/jcm11226818
Nov 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,000+ studies for 104 treatments. c19early.org
Discussion of limitations and concerns for1.
Reviews covering vitamin D for COVID-19 include2-34.
Nicoll et al., 18 Nov 2022, peer-reviewed, 2 authors. Contact: rachel.nicoll@umu.se (corresponding author).
This PaperVitamin DAll
COVID-19 Prevention: Vitamin D Is Still a Valid Remedy
Rachel Nicoll, Michael Y Henein
Journal of Clinical Medicine, doi:10.3390/jcm11226818
Seven meta-analyses and systematic reviews and three later clinical trials argued that low vitamin D status increased susceptibility to COVID-19 and the risk of greater disease severity and mortality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Furthermore, there are five meta-analyses and systematic reviews of vitamin D supplementation for the prevention of acute respiratory infection (ARI) [11, 12] and , as well as a later clinical trial [16], all showing that supplementation can protect against COVID-19 infection, disease severity, and death. The evidence could not be much more conclusive than this. Consequently, it was surprising to learn about Joliffe et al.'s recent randomized controlled trial of vitamin D to prevent ARIs and COVID-19, which concluded that 'Among people aged 16 years and older with suboptimal vitamin D status, implementation of a population level test-and-treat approach to vitamin D supplementation was not associated with a reduction in risk of all cause acute respiratory tract infection or . Joliffe et al.'s UK study was a test-and-treat approach used to determine the effect of correcting suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) < 75 nmol/L) on the risk of contracting ARIs and COVID-19. Those with 25(OH)D < 75 nmol/L (30 ng/mL) were randomized to six months of supplementary vitamin D at 3200 IU/day, 800 IU/day, or no supplements. The outcome was the percentage of subjects with confirmed ARI/COVID-19. What was different about this trial that might have caused it to fail? Analysis of Joliffe et al's paper gives rise to a number of observations. Of particular importance was the treatment of participants randomized to 'No supplementation'. Instead of being given a placebo, as would be normal in a controlled study, they were given nothing and were informed that it was a vitamin D trial, thereby alerting them to the fact that vitamin D supplementation could be an important infection preventive in the middle of the COVID-19 pandemic. As a result, almost 50% reported taking their own vitamin D supplements. We do not know what level of supplementation these participants took and we can assume that if 50% reported supplementation, the actual number was probably higher. As Dr David Grimes noted in a BMJ Rapid Response, this was therefore 'a randomised UNCONTROLLED study ' [18]; consequently, any comparison of the intervention arm with the 'no supplementation' arm was rendered meaningless. The authors sought to overcome this limitation by conducting sensitivity analysis, but this is no substitute for conducting a properly controlled trial. Furthermore, the authors took the unusual step of retesting those who had baseline vitamin D levels of ≥75 nmol/L (≥30 ng/mL) after 2 months. If they now proved to have vitamin D levels of <75 nmol/L (<30 ng/mL), they were included in the study and supplemented for four months. These new participants amounted to 11% in the lower dose group and 20% in the higher dose..
References
Barrett, Youssef, Shah, Ioana, Lawati et al., Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults, Nutrients, doi:10.3390/nu14163252
Bergman, Norlin, Hansen, Rekha, Agerberth et al., Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study, BMJ Open, doi:10.1136/bmjopen-2012-001663
Borsche, Glauner, Von Mendel, COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis, Nutrients, doi:10.3390/nu13103596
Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front. Public Health
Chiu, Tsai, Wu, Zheng, Yang et al., Putative Role of Vitamin D for COVID-19 Vaccination, Int. J. Mol. Sci, doi:10.3390/ijms22168988
D'ecclesiis, Gavioli, Martinoli, Raimondi, Chiocca et al., Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, PLoS ONE, doi:10.1371/journal.pone.0268396
Dissanayake, De Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis, J. Clin. Endocrinol. Metab, doi:10.1210/clinem/dgab892
Ebrahimzadeh, Mohseni, Narimani, Ebrahimzadeh, Kazemi et al., Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies, Crit. Rev. Food Sci. Nutr, doi:10.1080/10408398.2021.2012419
Grant, Boucher, Al Anouti, Pilz, Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D, Nutrients, doi:10.3390/nu14183811
Gönen, Alaylıo Glu, Durcan, Özdemir, Şahin et al., Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1, Nutrients, doi:10.3390/nu13114047
Hanggara, Iskandar, Susianti, Wahono, Pratama et al., The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination, J. Interferon Cytokine Res, doi:10.1089/jir.2021.0218
Israel, Cicurel, Feldhamer, Stern, Dror et al., Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case-control study, Intern. Emerg. Med, doi:10.1007/s11739-021-02902-w
Jolliffe, Camargo, Jr, Sluyter, Aglipay et al., Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol
Jolliffe, Holt, Greenig, Talaei, Perdek et al., Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and COVID-19: Phase 3 randomised controlled trial (CORONAVIT), BMJ, doi:10.1136/bmj-2022-071230
Jordan, Siuka, Rotovnik, Pfeifer, COVID-19 and Vitamin D-A Systematic Review, Slov. J. Public Health, doi:10.2478/sjph-2022-0017
Kaya, Pamukçu, Yakar, The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol. Health, doi:10.4178/epih.e2021074
Kerr, Bedston, Bradley, Joy, Lowthian et al., Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Int. J. Epidemiol, doi:10.1093/ije/dyac199
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Neves, Pott-Junior, De Sousa Santos, Cominetti, De Melo Freire et al., Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19, Clin. Nutr. ESPEN, doi:10.1016/j.clnesp.2022.05.027
Nikniaz, Akbarzadeh, Hosseinifard, Hosseini, The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis, Pharm. Sci
Oristrell, Oliva, Casado, Subirana, Domínguez et al., Vitamin D supplementation and COVID-19 risk: A population-based, cohort study, J. Endocrinol. Investig, doi:10.1007/s40618-021-01639-9
Piernas, Patone, Astbury, Gao, Sheikh et al., Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: A population-based cohort study, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(22)00158-9
Qin, Bouteau, Herbst, Igyártó, Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion, PLoS Pathog, doi:10.1371/journal.ppat.1010830
Sabico, Enani, Sheshah, Aljohani, Aldisi et al., Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial, Nutrients, doi:10.3390/nu13072170
Seal, Bertenthal, Carey, Grunfeld, Bikle et al., Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality, J. Gen. Intern. Med, doi:10.1007/s11606-021-07170-0
Seneff, Nigh, Kyriakopoulos, Mccullough, Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs, Food Chem. Toxicol, doi:10.1016/j.fct.2022.113008
Szarpak, Rafique, Gasecka, Chirico, Gawel et al., A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19, Cardiol. J
Tentolouris, Samakidou, Eleftheriadou, Tentolouris, Jude, The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression, Diabetes Metab. Res. Rev, doi:10.1002/dmrr.3517
Teshome, Adane, Girma, Mekonnen, The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis, Front. Public Health, doi:10.3389/fpubh.2021.624559
Villasis-Keever, López-Alarcón, Miranda-Novales, Zurita-Cruz, Barrada-Vázquez et al., Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial, Arch. Med. Res, doi:10.1016/j.arcmed.2022.04.003
{ 'indexed': { 'date-parts': [[2022, 11, 19]], 'date-time': '2022-11-19T06:03:03Z', 'timestamp': 1668837783945}, 'reference-count': 36, 'publisher': 'MDPI AG', 'issue': '22', 'license': [ { 'start': { 'date-parts': [[2022, 11, 18]], 'date-time': '2022-11-18T00:00:00Z', 'timestamp': 1668729600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Seven meta-analyses and systematic reviews and three later clinical trials argued ' 'that low vitamin D status increased susceptibility to COVID-19 and the risk of greater ' 'disease severity and mortality [...]</jats:p>', 'DOI': '10.3390/jcm11226818', 'type': 'journal-article', 'created': { 'date-parts': [[2022, 11, 18]], 'date-time': '2022-11-18T11:02:29Z', 'timestamp': 1668769349000}, 'page': '6818', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'COVID-19 Prevention: Vitamin D Is Still a Valid Remedy', 'prefix': '10.3390', 'volume': '11', 'author': [ {'given': 'Rachel', 'family': 'Nicoll', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-6089-5614', 'authenticated-orcid': False, 'given': 'Michael Y.', 'family': 'Henein', 'sequence': 'additional', 'affiliation': []}], 'member': '1968', 'published-online': {'date-parts': [[2022, 11, 18]]}, 'reference': [ { 'key': 'ref_1', 'doi-asserted-by': 'crossref', 'first-page': '1484', 'DOI': '10.1210/clinem/dgab892', 'article-title': 'Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic ' 'Review and Meta-analysis', 'volume': '107', 'year': '2022', 'journal-title': 'J. Clin. Endocrinol. Metab.'}, { 'key': 'ref_2', 'doi-asserted-by': 'crossref', 'first-page': '647', 'DOI': '10.5603/CJ.a2021.0072', 'article-title': 'A systematic review and meta-analysis of effect of vitamin D levels on ' 'the incidence of COVID-19', 'volume': '28', 'year': '2021', 'journal-title': 'Cardiol. J.'}, { 'key': 'ref_3', 'doi-asserted-by': 'crossref', 'first-page': '124', 'DOI': '10.2478/sjph-2022-0017', 'article-title': 'COVID-19 and Vitamin D—A Systematic Review', 'volume': '61', 'year': '2022', 'journal-title': 'Slov. J. Public Health'}, { 'key': 'ref_4', 'doi-asserted-by': 'crossref', 'first-page': 'e2021074', 'DOI': '10.4178/epih.e2021074', 'article-title': 'The role of vitamin D deficiency on COVID-19: A systematic review and ' 'meta-analysis of observational studies', 'volume': '43', 'year': '2021', 'journal-title': 'Epidemiol. Health'}, { 'key': 'ref_5', 'doi-asserted-by': 'crossref', 'first-page': '624559', 'DOI': '10.3389/fpubh.2021.624559', 'article-title': 'The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review ' 'and Meta-Analysis', 'volume': '9', 'year': '2021', 'journal-title': 'Front. Public Health'}, { 'key': 'ref_6', 'doi-asserted-by': 'crossref', 'unstructured': 'Ebrahimzadeh, A., Mohseni, S., Narimani, B., Ebrahimzadeh, A., Kazemi, ' 'S., Keshavarz, F., Yaghoubi, M.J., and Milajerdi, A. (2021). Association ' 'between vitamin D status and risk of COVID-19 in-hospital mortality: A ' 'systematic review and meta-analysis of observational studies. Crit. Rev. ' 'Food Sci. Nutr., 1–11.', 'DOI': '10.1080/10408398.2021.2012419'}, { 'key': 'ref_7', 'doi-asserted-by': 'crossref', 'unstructured': 'Borsche, L., Glauner, B., and von Mendel, J. (2021). COVID-19 Mortality ' 'Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate ' 'Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: ' 'Results of a Systematic Review and Meta-Analysis. Nutrients, 13.', 'DOI': '10.1101/2021.09.22.21263977'}, { 'key': 'ref_8', 'doi-asserted-by': 'crossref', 'first-page': '322', 'DOI': '10.1016/j.clnesp.2022.05.027', 'article-title': 'Vitamin D deficiency predicts 30-day hospital mortality of adults with ' 'COVID-19', 'volume': '50', 'year': '2022', 'journal-title': 'Clin. Nutr. ESPEN'}, { 'key': 'ref_9', 'doi-asserted-by': 'crossref', 'unstructured': 'Barrett, R., Youssef, M., Shah, I., Ioana, J., Lawati, A.A., Bukhari, ' 'A., Hegarty, S., Cormican, L.J., Judge, E., and Burke, C.M. (2022). ' 'Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of ' 'Unvaccinated Caucasian Adults. Nutrients, 14.', 'DOI': '10.3390/nu14163252'}, { 'key': 'ref_10', 'doi-asserted-by': 'crossref', 'first-page': '1053', 'DOI': '10.1007/s11739-021-02902-w', 'article-title': 'Vitamin D deficiency is associated with higher risks for SARS-CoV-2 ' 'infection and COVID-19 severity: A retrospective case-control study', 'volume': '17', 'year': '2022', 'journal-title': 'Intern. Emerg. Med.'}, { 'key': 'ref_11', 'first-page': 'i6583', 'article-title': 'Vitamin D supplementation to prevent acute respiratory tract ' 'infections: Systematic review and meta-analysis of individual ' 'participant data', 'volume': '356', 'year': '2017', 'journal-title': 'BMJ'}, { 'key': 'ref_12', 'doi-asserted-by': 'crossref', 'first-page': '276', 'DOI': '10.1016/S2213-8587(21)00051-6', 'article-title': 'Vitamin D supplementation to prevent acute respiratory infections: A ' 'systematic review and meta-analysis of aggregate data from randomised ' 'controlled trials', 'volume': '9', 'year': '2021', 'journal-title': 'Lancet Diabetes Endocrinol.'}, { 'key': 'ref_13', 'doi-asserted-by': 'crossref', 'unstructured': 'D’Ecclesiis, O., Gavioli, C., Martinoli, C., Raimondi, S., Chiocca, S., ' 'Miccolo, C., Bossi, P., Cortinovis, D., Chiaradonna, F., and Palorini, ' 'R. (2022). Vitamin D and SARS-CoV2 infection, severity and mortality: A ' 'systematic review and meta-analysis. PLoS ONE, 17.', 'DOI': '10.1371/journal.pone.0268396'}, { 'key': 'ref_14', 'first-page': 'e3517', 'article-title': 'The effect of vitamin D supplementation on mortality and intensive care ' 'unit admission of COVID-19 patients. A systematic review, meta-analysis ' 'and meta-regression', 'volume': '38', 'year': '2022', 'journal-title': 'Diabetes Metab. Res. Rev.'}, { 'key': 'ref_15', 'first-page': 'S1', 'article-title': 'The Impact of Vitamin D Supplementation on Mortality Rate and Clinical ' 'Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis', 'volume': '27', 'year': '2021', 'journal-title': 'Pharm. Sci.'}, { 'key': 'ref_16', 'unstructured': '(2022, November 16). Effect of Vitamin D3 Supplementation vs. ' 'Dietary-Hygienic Measures on SARS-COV-2 Infection Rates in Hospital ' 'Workers with 25-Hydroxyvitamin D3 [25(OH)D3] Levels ≥20 ng/mL. Available ' 'online: https://www.medrxiv.org/content/10.1101/2022.07.12.22277450v1.'}, { 'key': 'ref_17', 'first-page': 'e071230', 'article-title': 'Effect of a test-and-treat approach to vitamin D supplementation on ' 'risk of all cause acute respiratory tract infection and COVID-19: Phase ' '3 randomised controlled trial (CORONAVIT)', 'volume': '378', 'year': '2022', 'journal-title': 'BMJ'}, { 'key': 'ref_18', 'doi-asserted-by': 'crossref', 'unstructured': '(2022, November 16). Rapid Response to: Effect of a Test-and-Treat ' 'Approach to Vitamin D Supplementation on Risk of all Cause Acute ' 'Respiratory Tract Infection and COVID-19: Phase 3 Randomised Controlled ' 'Trial (CORONAVIT). Available online: ' 'https://www.bmj.com/content/378/bmj-2022-071230/rr.', 'DOI': '10.1136/bmj-2022-071230'}, { 'key': 'ref_19', 'doi-asserted-by': 'crossref', 'first-page': '736665', 'DOI': '10.3389/fpubh.2021.736665', 'article-title': 'Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical ' 'Outcomes', 'volume': '9', 'year': '2021', 'journal-title': 'Front. Public Health'}, { 'key': 'ref_20', 'doi-asserted-by': 'crossref', 'first-page': '853', 'DOI': '10.1007/s11606-021-07170-0', 'article-title': 'Association of Vitamin D Status and COVID-19-Related Hospitalization ' 'and Mortality', 'volume': '37', 'year': '2022', 'journal-title': 'J. Gen. Intern. Med.'}, { 'key': 'ref_21', 'doi-asserted-by': 'crossref', 'first-page': 'e001663', 'DOI': '10.1136/bmjopen-2012-001663', 'article-title': 'Vitamin D3 supplementation in patients with frequent respiratory tract ' 'infections: A randomised and double-blind intervention study', 'volume': '2', 'year': '2012', 'journal-title': 'BMJ Open'}, { 'key': 'ref_22', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1016/j.arcmed.2022.04.003', 'article-title': 'Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in ' 'Frontline Healthcare Workers. A Randomized Clinical Trial', 'volume': '53', 'year': '2022', 'journal-title': 'Arch. Med. Res.'}, { 'key': 'ref_23', 'doi-asserted-by': 'crossref', 'unstructured': 'Sabico, S., Enani, M.A., Sheshah, E., Aljohani, N.J., Aldisi, D.A., ' 'Alotaibi, N.H., Alshingetti, N., Alomar, S.Y., Alnaami, A.M., and Amer, ' 'O.E. (2021). Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 ' 'Supplementation on Recovery of Symptoms in Patients with Mild to ' 'Moderate Covid-19: A Randomized Clinical Trial. Nutrients, 13.', 'DOI': '10.3390/nu13072170'}, { 'key': 'ref_24', 'doi-asserted-by': 'crossref', 'unstructured': 'Gönen, M.S., Alaylıoğlu, M., Durcan, E., Özdemir, Y., Şahin, S., ' 'Konukoğlu, D., Nohut, O.K., Ürkmez, S., Küçükece, B., and Balkan, İ.İ. ' '(2021). Rapid and Effective Vitamin D Supplementation May Present Better ' 'Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum ' 'INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients, 13.', 'DOI': '10.3390/nu13114047'}, { 'key': 'ref_25', 'doi-asserted-by': 'crossref', 'first-page': '167', 'DOI': '10.1007/s40618-021-01639-9', 'article-title': 'Vitamin D supplementation and COVID-19 risk: A population-based, cohort ' 'study', 'volume': '45', 'year': '2022', 'journal-title': 'J. Endocrinol. Investig.'}, { 'key': 'ref_26', 'doi-asserted-by': 'crossref', 'unstructured': 'Grant, W.B., Boucher, B.J., Al Anouti, F., and Pilz, S. (2022). ' 'Comparing the Evidence from Observational Studies and Randomized ' 'Controlled Trials for Nonskeletal Health Effects of Vitamin D. ' 'Nutrients, 14.', 'DOI': '10.3390/nu14183811'}, { 'key': 'ref_27', 'doi-asserted-by': 'crossref', 'unstructured': 'Qin, Z., Bouteau, A., Herbst, C., and Igyártó, B.Z. (2022). Pre-exposure ' 'to mRNA-LNP inhibits adaptive immune responses and alters innate immune ' 'fitness in an inheritable fashion. PLoS Pathog., 18.', 'DOI': '10.1101/2022.03.16.484616'}, { 'key': 'ref_28', 'unstructured': '(2022, November 02). The BNT162b2 mRNA Vaccine Against SARS-CoV-2 ' 'Reprograms both Adaptive and Innate Immune Responses. Available online: ' 'https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1.full.'}, { 'key': 'ref_29', 'doi-asserted-by': 'crossref', 'first-page': '113008', 'DOI': '10.1016/j.fct.2022.113008', 'article-title': 'Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of ' 'G-quadruplexes, exosomes, and MicroRNAs', 'volume': '164', 'year': '2022', 'journal-title': 'Food Chem. Toxicol.'}, { 'key': 'ref_30', 'doi-asserted-by': 'crossref', 'unstructured': 'Chiu, S.-K., Tsai, K.-W., Wu, C.-C., Zheng, C.-M., Yang, C.-H., Hu, ' 'W.-C., Hou, Y.-C., Lu, K.-C., and Chao, Y.-C. (2021). Putative Role of ' 'Vitamin D for COVID-19 Vaccination. Int. J. Mol. Sci., 22.', 'DOI': '10.3390/ijms22168988'}, { 'key': 'ref_31', 'doi-asserted-by': 'crossref', 'first-page': '329', 'DOI': '10.1089/jir.2021.0218', 'article-title': 'The Role of Vitamin D for Modulating the T Helper 1 Immune Response ' 'After the Coronavac Vaccination', 'volume': '42', 'year': '2022', 'journal-title': 'J. Interferon Cytokine Res.'}, { 'key': 'ref_32', 'doi-asserted-by': 'crossref', 'first-page': '571', 'DOI': '10.1016/S2213-8587(22)00158-9', 'article-title': 'Associations of BMI with COVID-19 vaccine uptake, vaccine ' 'effectiveness, and risk of severe COVID-19 outcomes after vaccination ' 'in England: A population-based cohort study', 'volume': '10', 'year': '2022', 'journal-title': 'Lancet Diabetes Endocrinol.'}, { 'key': 'ref_33', 'doi-asserted-by': 'crossref', 'unstructured': 'Kerr, S., Bedston, S., Bradley, D.T., Joy, M., Lowthian, E., Mulholland, ' 'R.M., Akbari, A., Hobbs, F.D.R., Katikireddi, S.V., and de Lusignan, S. ' '(2022). Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 ' 'vaccinations: A pooled target trial study of 12.9 million individuals in ' 'England, Northern Ireland, Scotland and Wales. Int. J. Epidemiol., ' 'dyac199.', 'DOI': '10.1093/ije/dyac199'}, { 'key': 'ref_34', 'unstructured': '(2022, November 02). Effectiveness of mRNA-1273 Against Infection and ' 'COVID-19 Hospitalization with SARS-CoV-2 Omicron Subvariants: BA.1, ' 'BA.2, BA.2.12.1, BA.4, and BA.5. Available online: ' 'https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v1.'}, { 'key': 'ref_35', 'unstructured': '(2022, November 02). Effectiveness of COVID-19 Vaccines Over 13 Months ' 'Covering the Period of the Emergence of the Omicron Variant in the ' 'Swedish Population. Available online: ' 'https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4224504.'}, { 'key': 'ref_36', 'unstructured': '(2022, November 02). Atypical B Cells and Impaired SARS-CoV-2 ' 'Neutralisation Following Booster Vaccination in the Elderly. Available ' 'online: https://www.medrxiv.org/content/10.1101/2022.10.13.22281024v1.'}], 'container-title': 'Journal of Clinical Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.mdpi.com/2077-0383/11/22/6818/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 11, 18]], 'date-time': '2022-11-18T12:46:31Z', 'timestamp': 1668775591000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.mdpi.com/2077-0383/11/22/6818'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 11, 18]]}, 'references-count': 36, 'journal-issue': {'issue': '22', 'published-online': {'date-parts': [[2022, 11]]}}, 'alternative-id': ['jcm11226818'], 'URL': 'http://dx.doi.org/10.3390/jcm11226818', 'relation': {}, 'ISSN': ['2077-0383'], 'subject': ['General Medicine'], 'container-title-short': 'JCM', 'published': {'date-parts': [[2022, 11, 18]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit